KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Invested Capital (2016 - 2025)

Novartis Ag's Invested Capital history spans 11 years, with the latest figure at $46.4 billion for Q4 2025.

  • On a quarterly basis, Invested Capital rose 3.99% to $46.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $46.4 billion, a 3.99% increase, with the full-year FY2025 number at $46.4 billion, up 3.99% from a year prior.
  • Invested Capital hit $46.4 billion in Q4 2025 for Novartis Ag, up from $44.6 billion in the prior quarter.
  • Over the last five years, Invested Capital for NVS hit a ceiling of $90.7 billion in Q4 2022 and a floor of $44.6 billion in Q4 2024.
  • Historically, Invested Capital has averaged $59.8 billion across 5 years, with a median of $47.4 billion in 2023.
  • Biggest five-year swings in Invested Capital: skyrocketed 10355.86% in 2021 and later plummeted 47.76% in 2023.
  • Tracing NVS's Invested Capital over 5 years: stood at $69.6 billion in 2021, then soared by 30.23% to $90.7 billion in 2022, then plummeted by 47.76% to $47.4 billion in 2023, then decreased by 5.75% to $44.6 billion in 2024, then rose by 3.99% to $46.4 billion in 2025.
  • Business Quant data shows Invested Capital for NVS at $46.4 billion in Q4 2025, $44.6 billion in Q4 2024, and $47.4 billion in Q4 2023.